MON - Monsanto Company

NYSE - NYSE Delayed Price. Currency in USD
125.31
-0.42 (-0.33%)
At close: 4:01PM EDT

125.31 0.00 (0.00%)
After hours: 5:24PM EDT

Stock chart is not supported by your current browser
Previous Close125.73
Open125.69
Bid0.00 x 1100
Ask126.30 x 800
Day's Range125.08 - 125.90
52 Week Range114.19 - 126.80
Volume2,979,744
Avg. Volume3,789,617
Market Cap55.297B
Beta0.92
PE Ratio (TTM)22.45
EPS (TTM)5.58
Earnings DateJun 26, 2018 - Jul 2, 2018
Forward Dividend & Yield2.16 (1.72%)
Ex-Dividend DateN/A
1y Target Est126.40
Trade prices are not sourced from all markets
  • Market Exclusive15 hours ago

    Market Morning Roundup – Futures Down, Facebook Wants Your SSN, Fed Minutes, Weed-Killing Robots

    Asian Shares Down Overnight, Futures Fall In a hint that yesterday’s end-of-day selloff would continue at the open today, Japanese shares were down over 1% along with most Asian indexes. A few hours later, US stocks futures took a dive. The level to watch on the S&P 500 (^GSPC) today is 2,675, the current 50 […] The post Market Morning Roundup – Futures Down, Facebook Wants Your SSN, Fed Minutes, Weed-Killing Robots appeared first on Market Exclusive.

  • Landmark lawsuit claims Monsanto hid cancer danger of weedkiller for decades
    The Guardian2 days ago

    Landmark lawsuit claims Monsanto hid cancer danger of weedkiller for decades

    Monsanto has been accused of hiding the dangers of its popular Roundup products for decades, a claim the company denies. At the age of 46, DeWayne Johnson is not ready to die. Now Johnson, a husband and father of three in California, hopes to survive long enough to make Monsanto take the blame for his fate.

  • Why Bill Gates is betting on a start-up that prints synthetic DNA
    CNBC2 days ago

    Why Bill Gates is betting on a start-up that prints synthetic DNA

    Bill Gates is investing in Ginkgo Bioworks, a Boston-based start-up that prints its own designer DNA from a computer and is developing one of the world's largest libraries of usable genetic code.

  • ACCESSWIRE3 days ago

    Free Technical Research on Mosaic and Three More Agricultural Chemicals Equities

    WallStEquities.com has initiated research coverage on Monsanto Co. (NYSE: MON), Nutrien Ltd (NTR), The Mosaic Co. (NYSE: MOS), and The Scotts Miracle-Gro Co. (NYSE: SMG). Last Friday at the close, shares in St. Louis, Missouri-based Monsanto Co. ended 0.29% higher at $125.85.

  • Corteva Agriscience™, Agriculture Division of DowDuPont, and Monsanto Company Reach Licensing Agreement on Next-Generation Corn Insect Control Technology
    Business Wire7 days ago

    Corteva Agriscience™, Agriculture Division of DowDuPont, and Monsanto Company Reach Licensing Agreement on Next-Generation Corn Insect Control Technology

    Corteva Agriscience™, Agriculture Division of DowDuPont (DWDP), and Monsanto Company (MON) announced today the completion of a licensing agreement for next-generation technology for insect control in corn for the U.S. and Canada that will expand options for farmers fighting corn rootworm, dubbed the “billion dollar bug” for the damage it causes. Corteva Agriscience™ will receive a license to stack Monsanto’s Corn Rootworm III and MON89034 traits with Corteva Agriscience’s insect control traits.

  • After-hours buzz: TEVA, MON, MU & more
    CNBC8 days ago

    After-hours buzz: TEVA, MON, MU & more

    See which stocks are posting big moves after the bell.

  • Buffett's Berkshire adds to stakes in Teva and Monsanto in the first quarter
    CNBC8 days ago

    Buffett's Berkshire adds to stakes in Teva and Monsanto in the first quarter

    Berkshire Hathaway more than doubled its stake in the Israeli pharmaceutical company Teva in the first quarter, to 40.5 million shares.

  • CNBC8 days ago

    Buffett's Berkshire adds to stakes in Teva and Monsanto in the first quarter

    The changes are reflected in Berkshire's quarterly regulatory filing but only report holdings as of the end of March. Buffett told CNBC earlier this month the conglomerate had exited its holdings of International Business Machines and added 75 million shares of Apple in the quarter. Warren Buffett's Berkshire Hathaway BRK.A reported larger holdings of the Israeli pharmaceutical company Teva Pharmaceutical TEVA and the St. Louis-based agricultural product giant Monsanto MON in the first quarter.

  • Deere’s Expected Fiscal Second-Quarter Revenues
    Market Realist8 days ago

    Deere’s Expected Fiscal Second-Quarter Revenues

    Deere (DE) is expected to report revenues of $9.81 billion in the fiscal second quarter from its equipment operations. In the second fiscal quarter of 2017, Deere reported revenues of $7.26 billion from equipment operations. If Deere meets the revenue expectations, it would be the highest second quarter revenues since the second fiscal quarter of 2013.

  • Deere: Strong Adjusted Earnings Are Expected in Q2
    Market Realist8 days ago

    Deere: Strong Adjusted Earnings Are Expected in Q2

    Deere (DE) is expected to post an adjusted EPS (earnings per share) of $3.31 for the second fiscal quarter—an increase of 32.9% on a YoY (year-over-year) basis. In the second fiscal quarter of 2017, Deere reported an EPS of $2.49. Deere managed to beat analysts’ estimates in the first fiscal quarter.

  • Bayer CFO sees lower Monsanto synergies after divestments: Boersen-Zeitung
    Reuters12 days ago

    Bayer CFO sees lower Monsanto synergies after divestments: Boersen-Zeitung

    Bayer's potential synergies from buying U.S. rival Monsanto will be lower than $1.5 billion because of anti-trust divestments, the German company's Chief Financial Officer told Germany's Boersen-Zeitung. The $1.5 billion savings targeted within three years are a "pro forma" synergy goal, which excluded the impact of divestments, Johannes Dietsch told the newspaper. "The basis for revenue synergies is now lower.

  • Bayer CFO sees lower Monsanto synergies after divestments: Boersen-Zeitung
    Reuters12 days ago

    Bayer CFO sees lower Monsanto synergies after divestments: Boersen-Zeitung

    Bayer's potential synergies from buying U.S. rival Monsanto will be lower than $1.5 billion because of anti-trust divestments, the German company's Chief Financial Officer told Germany's Boersen-Zeitung. The $1.5 billion savings targeted within three years are a "pro forma" synergy goal, which excluded the impact of divestments, Johannes Dietsch told the newspaper. "The basis for revenue synergies is now lower.

  • Why IFF Flavors Segment’s Profit Margin Expanded
    Market Realist14 days ago

    Why IFF Flavors Segment’s Profit Margin Expanded

    International Flavors and Fragrances’ (IFF) Flavors segment saw a fall in its revenue contribution by 0.8 percentage points to the company’s overall revenue in 1Q18. The growth in the segment’s revenue was primarily driven by higher volume growth across most of the reporting regions. EMEA (Europe, the Middle East, and Africa) led with growth of 24% driven by the strong performance in the dairy, savory, and beverage businesses. North America revenue grew by 10% due to double-digit growth in Tastepoint along with the new business wins in the beverage and dairy businesses. Asia witnessed revenue growth of 6% resulting from double-digit growth in China and India.

  • DWDP’s Material Science Segment: Higher Revenue Growth in 1Q18
    Market Realist16 days ago

    DWDP’s Material Science Segment: Higher Revenue Growth in 1Q18

    DowDuPont’s (DWDP) Material Science segment, which is expected to be spun off into a new company by the end of 1Q19, accounted for 55.9% of its total revenues. The Performance Materials & Coatings business grew 12.0%, driven by higher volume growth due to continued higher demand. The Industrial Intermediates and Infrastructure business’s revenues grew 30.0% owing to new client wins and higher pricing.

  • Weather Impacts DowDuPont’s 1Q18 Agriculture Segment
    Market Realist16 days ago

    Weather Impacts DowDuPont’s 1Q18 Agriculture Segment

    DowDuPont’s (DWDP) Agriculture segment accounted for 17.7% of DWDP’s 1Q18 revenues, compared to 24.7% in 1Q17 on a pro forma basis. This segment reported revenues of ~$3.8 billion in 1Q18, a decrease of 24.6% on a year-over-year basis.

  • DowDuPont Sees Revenue Beat despite Agriculture Segment’s Slump
    Market Realist16 days ago

    DowDuPont Sees Revenue Beat despite Agriculture Segment’s Slump

    DowDuPont (DWDP) reported 1Q18 revenues of $21.5 billion, an increase of 13.1% over its pro forma revenues of $20.5 billion in 1Q17. Analysts expected DWDP to report revenues of ~$21.4 billion. The company’s revenues are reported on a continuing operations basis. Dow Chemical and DuPont made several significant divestitures to facilitate the merger.

  • DowDuPont’s 1Q18 Earnings Beats Expectations
    Market Realist16 days ago

    DowDuPont’s 1Q18 Earnings Beats Expectations

    DowDuPont (DWDP) announced its 1Q18 earnings before the market opened on May 3. It reported adjusted earnings per share (or EPS) of $1.12, an increase of 6.7% over its pro forma adjusted earnings per share of $1.05. The company beat the analysts’ adjusted earnings per share estimate of $1.10. In this series, we’ll look at DowDuPont’s earnings, revenues, and segment-wise performance.

  • The Canadian Press16 days ago

    Monsanto CEO and others to leave after Bayer takeover

    Monsanto Chairman and CEO Hugh Grant will leave the company after it's acquired by Germany's Bayer AG. The St. Louis company said Monday that Grant will work to see the $57 billion deal through and oversee operations before it closes. Bayer expects the deal to close in the second quarter.

  • The Canadian Press16 days ago

    Monsanto CEO and others to leave after Bayer takeover

    Monsanto Chairman and CEO Hugh Grant will leave the company after it's acquired by Germany's Bayer AG. The St. Louis company said Monday that Grant will work to see the $57 billion deal through and oversee operations before it closes. Bayer expects the deal to close in the second quarter.

  • Monsanto CEO Grant to make way for Bayer's Condon post-takeover
    Reuters16 days ago

    Monsanto CEO Grant to make way for Bayer's Condon post-takeover

    Grant became CEO in 2003 and will leave following the close of the deal, along with other senior executives including Chief Financial Officer Pierre Courduroux and Chief Technology Officer Robert Fraley, Monsanto said on Monday. German conglomerate Bayer is preparing to close its $62.5 billion (46.1 billion pounds) takeover of Monsanto this quarter, giving it control of more than 25 percent of the world's seed and pesticides market.

  • The Wall Street Journal17 days ago

    [$$] Monsanto CEO to Leave After Sale to Bayer

    Mr. Grant has worked at Monsanto for 35 years and has served as chairman and CEO since 2003. and a number of other top executives, such as the company’s general counsel and chief technology officer, are also leaving after the deal is completed, Monsanto said Monday.

  • MarketWatch17 days ago

    Monsanto CEO Hugh Grant says he will step down once the Bayer deal closes

    Monsanto Co. Chief Executive Hugh Grant said Monday he will step down and leave the company once the company's takeover by Bayer AG has closed. Grant will remain as CEO and chairman until then, he said ...

  • Business Wire17 days ago

    Monsanto Company Chairman And Chief Executive Officer Hugh Grant Announces Intent To Leave Monsanto Upon Closing Of Bayer Acquisition

    Monsanto Company (MON) Chairman and Chief Executive Officer Hugh Grant announced today his intent to leave Monsanto at the closing of the acquisition of Monsanto by Bayer AG. Grant will maintain his position as Chairman and Chief Executive Officer until closing, continuing to focus on leading the company on its top objectives of securing deal approval and delivering on its underlying business priorities. Bayer continues to target closing in the second calendar quarter of 2018.

  • GlobeNewswire17 days ago

    Market Trends Toward New Normal in Forestar Group, Altria Group, Investors, Brighthouse Financial, Monsanto, and Cleveland-Cliffs — Emerging Consolidated Expectations, Analyst Ratings

    NEW YORK, May 07, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Forestar ...

  • Monsanto (MON) Up 6% Since Earnings Report: Can it Continue?
    Zacks17 days ago

    Monsanto (MON) Up 6% Since Earnings Report: Can it Continue?

    Monsanto (MON) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.